Harvard researchers engineer proteins

Researchers prove they can engineer proteins to find new targets with high selectivity, a critical advance toward potential new treatments to help neuroregeneration, cytokine storm.

Caitlin McDermott-Murphy • harvard
March 4, 2021 ~7 min

Anti-inflammatory drug improves survival in COVID-19 patients

Researchers have found that a targeted therapy with tocilizumab reduced mortality by 30 percent for critically ill COVID-19 patients when administered within the first two days of ICU admission.

Haley Bridger • harvard
Oct. 20, 2020 ~8 min

An optimistic outlook may be a healthier one

A Harvard Chan School study has found a link between optimism and hypertension, describing the positive force as having a “protective effect” on individuals, including those in combat.

Amy Roeder • harvard
Sept. 24, 2020 ~6 min

Study finds promising results using acupuncture to treat inflammation

Acupuncture activates inflammation-regulating pathways, tames cytokine storm in mice.

Ekaterina Pesheva • harvard
Aug. 12, 2020 ~10 min

Harvard scientists identify gut-brain connection in ALS

The researchers found that in mice with a common ALS genetic mutation, changing the gut microbiome could prevent or improve disease symptoms.

Jessica Lau • harvard
May 13, 2020 ~5 min

FDA-approved drug shows promise against ALS in mice

Accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of amyotrophic lateral sclerosis (ALS).

Harvard Gazette • harvard
Nov. 27, 2019 ~3 min

Harvard researchers look toward nature to beat cancer

Every year, more than 18 million people around the world are told, “You have cancer.” In the U.S., nearly half of all men and more than one-third of women will develop some kind of cancer during their lifetimes, and 600,000-plus die from it annually. Despite the billions of dollars and countless new treatments that have […]

Lindsay Brownell • harvard
March 1, 2019 ~24 min

Interaction between immune factors triggers cancer-promoting chronic inflammation

Harvard researchers found that interaction between immune factors triggers cancer-promoting chronic inflammation, setting the stage for the development of skin cancer associated with chronic dermatitis and colorectal cancer in patients with colitis.

Sue McGreevey • harvard
Feb. 11, 2019 ~4 min

/

1